Ironwood Pharmaceuticals (NASDAQ:IRWD – Get Free Report) was upgraded by equities researchers at StockNews.com from a “hold” rating to a “buy” rating in a research note issued to investors on Thursday ...

Hello, and welcome to the Bit Digital Fiscal Year 2024 earnings conference call. Good morning, good afternoon and good evening, depending on where you're joining us from. Thank you for being here.